FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – USA – 03/2025”.
The Monitor is a month-to-month revealed overview of enterprise capital tendencies within the US Healthcare & Life Sciences sector.
As of the top of March 2025 we recognized the next present VC tendencies in the US:
- Complete Healthcare & Life Sciences funding reached EUR 9,498m (-3% vs. 2024)
- Biotech/Pharma obtained 43% of the whole funding quantity (EUR 4,081m) with immunology being the main indication (25%)
- In March Supira Medical secured the highest transaction quantity with EUR 112m, adopted by SetPoint Medical with EUR 107m and Curevo Vaccine with EUR 104m
- Illumina (United States) is probably the most lively investor (by deal quantity in 2025), adopted by Regeneron Prescribed drugs (United States) and The Column Group (United States)
To entry the complete report, please click on right here.
By Mathias Klozenbücher und Johannes Hyperlink